- Corporate Officers - A
- Amgen Inc
Insider Trading History of Amgen Inc
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Amgen Inc since 2013.
This trader's CIK number is 318154.
At the time of last reporting, Amgen Inc was the Officer of Neumora Therapeutics, Inc.. (stock ticker symbol NMRA).
Also see all insider trading activities at Neumora Therapeutics, Inc..
Note that in the past
AMGEN INC also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Neumora Therapeutics, Inc. (NMRA) by Amgen Inc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2023 | NMRA | 1,764,705 | $29,999,985 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Beigene, Ltd. (BGNE) by Amgen Inc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2021 | BGNE | 165,529 | $50,000,020 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Epizyme, Inc. (EPZM) by Amgen Inc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2013 | EPZM | 16,666 | $249,990 | 0 | $0 | 0 | $0 |
Insider trading activities at 3 companies by Amgen Inc:
1. Neumora Therapeutics, Inc. (NMRA)
2. Beigene, Ltd. (BGNE)
3. Epizyme, Inc. (EPZM)
Table 1. Insider trading of Neumora Therapeutics, Inc. (NMRA) by Amgen Inc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2023-09-19 | NMRA | Buy | 1,764,705 | 17.00 | 29,999,985 |
Table 2. Insider trading of Beigene, Ltd. (BGNE) by Amgen Inc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2021-09-10 | BGNE | Buy | 165,529 | 302.06 | 50,000,020 |
Table 3. Insider trading of Epizyme, Inc. (EPZM) by Amgen Inc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2013-06-05 | EPZM | Buy | 16,666 | 15.00 | 249,990 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Amgen Inc
(Officer of Neumora Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.